BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28430739)

  • 1. Downstream indication to revascularization following hybrid cardiac PET/MRI: preliminary results.
    Priamo J; Adamopoulos D; Rager O; Frei A; Noble S; Carballo D; Ratib O; Nkoulou R
    Nucl Med Commun; 2017 Jun; 38(6):515-522. PubMed ID: 28430739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET/MRI early after myocardial infarction: evaluation of viability with late gadolinium enhancement transmurality vs. 18F-FDG uptake.
    Rischpler C; Langwieser N; Souvatzoglou M; Batrice A; van Marwick S; Snajberk J; Ibrahim T; Laugwitz KL; Nekolla SG; Schwaiger M
    Eur Heart J Cardiovasc Imaging; 2015 Jun; 16(6):661-9. PubMed ID: 25680385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of (99m)Tc-MIBI SPECT/18F-FDG PET imaging and cardiac magnetic resonance imaging in patients with idiopathic dilated cardiomyopathy: assessment of cardiac function and myocardial injury.
    Wang L; Yan C; Zhao S; Fang W
    Clin Nucl Med; 2012 Dec; 37(12):1163-9. PubMed ID: 23154474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Analysis of Myocardial Viability Multimodality Imaging in Patients with Previous Myocardial Infarction and Symptomatic Heart Failure.
    Kazakauskaite E; Vajauskas D; Unikaite R; Jonauskiene I; Virbickiene A; Zaliaduonyte D; Lapinskas T; Jurkevicius R
    Medicina (Kaunas); 2022 Mar; 58(3):. PubMed ID: 35334543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of contrast-enhanced MRI with (18)F-FDG PET/201Tl SPECT in dysfunctional myocardium: relation to early functional outcome after surgical revascularization in chronic ischemic heart disease.
    Wu YW; Tadamura E; Yamamuro M; Kanao S; Marui A; Tanabara K; Komeda M; Togashi K
    J Nucl Med; 2007 Jul; 48(7):1096-103. PubMed ID: 17607039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of viable myocardium through delayed enhancement cardiac magnetic resonance imaging combined with
    Xu D; Zhang J; Liu B; Fu D; Li J; Fan L
    Int J Cardiovasc Imaging; 2024 Apr; 40(4):887-895. PubMed ID: 38265540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential PET/diffusion-weighted imaging in the evaluation of myocardial perfusion and viability in coronary artery disease: a preliminary study.
    Ling X; Chen J; Shang J; Tang Y; Cheng Y; Xu H
    Nucl Med Commun; 2020 Jan; 41(1):40-47. PubMed ID: 31764594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of myocardial viability imaging by cardiac MRI and PET depending on left ventricular function.
    Hunold P; Jakob H; Erbel R; Barkhausen J; Heilmaier C
    World J Cardiol; 2018 Sep; 10(9):110-118. PubMed ID: 30344958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of FDG-PET in myocarditis: Comparison to CMR using integrated PET/MRI.
    Nensa F; Kloth J; Tezgah E; Poeppel TD; Heusch P; Goebel J; Nassenstein K; Schlosser T
    J Nucl Cardiol; 2018 Jun; 25(3):785-794. PubMed ID: 27638745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of reversible myocardial dysfunction in chronic ischaemic heart disease: comparison of contrast-enhanced cardiovascular magnetic resonance and a combined positron emission tomography-single photon emission computed tomography imaging protocol.
    Kühl HP; Lipke CS; Krombach GA; Katoh M; Battenberg TF; Nowak B; Heussen N; Buecker A; Schaefer WM
    Eur Heart J; 2006 Apr; 27(7):846-53. PubMed ID: 16434414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional myocardial damage and active inflammation in patients with cardiac sarcoidosis detected by non-invasive multi-modal imaging.
    Kataoka S; Momose M; Fukushima K; Serizawa N; Suzuki A; Kondo C; Abe K; Sakai S; Hagiwara N
    Ann Nucl Med; 2017 Feb; 31(2):135-143. PubMed ID: 27804054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Myocardial Viability in Ischemic Heart Disease by PET/MRI: Comparison of Left Ventricular Perfusion, Hibernation, and Scar Burden.
    Beitzke D; Rasul S; Lassen ML; Pichler V; Senn D; Stelzmüller ME; Nolz R; Loewe C; Hacker M
    Acad Radiol; 2020 Feb; 27(2):188-197. PubMed ID: 31053482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial viability in chronic ischemic heart disease: comparison of delayed-enhancement magnetic resonance imaging with 99mTc-sestamibi and 18F-fluorodeoxyglucose single-photon emission computed tomography.
    Liu Q; Zhao S; Yan C; Lu M; Jiang S; Zhang Y; Li S; Liu Y; Yang M; He Z
    Nucl Med Commun; 2009 Aug; 30(8):610-6. PubMed ID: 19491715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome of patients with previous myocardial infarction and left ventricular dysfunction assessed with myocardial (99m)Tc-MIBI SPECT and (18)F-FDG PET.
    Zhang X; Liu XJ; Wu Q; Shi R; Gao R; Liu Y; Hu S; Tian Y; Guo S; Fang W
    J Nucl Med; 2001 Aug; 42(8):1166-73. PubMed ID: 11483675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging in determination of myocardial ischemia and viability: comparison with positron emission tomography and single-photon emission computed tomography in a porcine model.
    Wang L; Zhu HY; Tian JM; Huang SD; Kong LS; Lu JP
    Acta Radiol; 2007 Jun; 48(5):500-7. PubMed ID: 17520425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial viability by contrast-enhanced cardiovascular magnetic resonance in patients with coronary artery disease: comparison with gated single-photon emission tomography and FDG position emission tomography.
    Wu YW; Tadamura E; Kanao S; Yamamuro M; Marui A; Komeda M; Toma M; Kimura T; Togashi K
    Int J Cardiovasc Imaging; 2007 Dec; 23(6):757-65. PubMed ID: 17364219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease.
    vom Dahl J; Altehoefer C; Sheehan FH; Buechin P; Schulz G; Schwarz ER; Koch KC; Uebis R; Messmer BJ; Buell U; Hanrath P
    J Nucl Med; 1997 May; 38(5):742-8. PubMed ID: 9170439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining FDG-PET and 99mTc-SPECT to predict functional outcome after coronary artery bypass surgery.
    Lehtinen M; Schildt J; Ahonen A; Nikkinen P; Lauerma K; Sinisalo J; Kankuri E; Vento A; Pätilä T; Harjula A;
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):1023-30. PubMed ID: 25762563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of myocardial viability with contrast-enhanced magnetic resonance imaging--comparison of the late enhancement technique with positronemission tomography].
    Hunold P; Brandt-Mainz K; Freudenberg L; Vogt FM; Neumann T; Knipp S; Barkhausen J
    Rofo; 2002 Jul; 174(7):867-73. PubMed ID: 12101477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose dobutamine stress gated SPET for identification of viable myocardium: comparison with stress-rest perfusion SPET and PET.
    Yoshinaga K; Katoh C; Noriyasu K; Yamada S; Ito Y; Kuge Y; Kawai Y; Kohya T; Kitabatake A; Tamaki N
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):882-90. PubMed ID: 12111128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.